Categories: DevelopmentHealthTechMedTechProductServiceTechnology
Medtronic is a global leader in medical technology, services, and solutions. We collaborate with others to take on healthcare's greatest challenges. See how.
Investors 2
Mentions in press and media 6
| Date | Title | Description |
| 23.11.2010 | Medtronic makes $800 million acquisition of Ardian | Medtronic Inc. (NYSE:MDT) picked up another cardiovascular device company in the latest of a series of acquisitions.
The largest medical device maker in the world today announced an agreement to acquire hypertension treatment developer Ardi... |
| 18.11.2010 | FDA keeps Medtronic pacemaker, defibrillator sales on hold | The FDA’s Nov. 2009 warning letter said that Medtronic’s “methods used in, or the facilities or controls used for, [the devices’] manufacture, packing, storage or installation are not in conformity with the Current Good Manufacturing Practi... |
| 17.11.2010 | FDA keeps Medtronic waiting on pacemakers | Certain pacemakers and implantable defibrillators made by Medtronic Inc. (NYSE:MDT) can’t be sold in the U.S., but the company can’t figure out why.
The Fridley, Minn.-based company received a warning letter from the Food & Drug Adminis... |
| 17.08.2010 | Medtronic to acquire troubled biologics company for $123M | Medtronic Inc. (NYSE: MDT) said Tuesday it will purchase Osteotech Inc. (NASDAQ: OSTE) for $123 million.
The world’s largest medical device maker, based in Fridley, Minnesota, said it would pay $6.50 for each Osteotech share, a 65 percent p... |
| - | FDA keeps Medtronic pacemaker, defibrillator sales on hold | Certain pacemakers and implantable defibrillators made by Medtronic Inc. (NYSE:MDT) can’t be sold in the U.S., but the company can’t figure out why.
The Fridley, Minnesota-based company received a warning letter from the Food & Drug Adm... |
| - | Medtronic to acquire troubled biologics company for $123M | Medtronic Inc. (NYSE: MDT) said Tuesday it will purchase Osteotech Inc. (NASDAQ: OSTE) for $123 million.
The world’s largest medical device maker, based in Fridley, Minnesota, said it would pay $6.50 for each Osteotech share, a 65 percent p... |
Reviews 0
